ACE2 and COVID-19: Notably, several reports show that higher levels of ACE2 protein/activity are associated with advanced age, male sex, cardiopathies, hypertension, diabetes, dyslipidaemias and atherosclerotic plaques [7,8,20,21,22,23,24,25,26,27], which are also the main risk factors for COVID-19 complications.